Home » Topics » BioWorld Science

BioWorld Science
RSS

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

June 13, 1997

Gensia receives FDA approval of ANDA for atracurium besilate

June 13, 1997

KW-3902 may be beneficial in hemorrhagic shock

June 13, 1997

Combination insulin sensitizer + alpha-glucosidase inhibitor for diabetes

June 13, 1997

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

June 13, 1997

Favorable preclinical results with REPEL-CV for cardiovascular surgery

June 13, 1997

Fibrinogen antagonists in IDDM

June 13, 1997

Results of D1/D2 receptor coactivation in diabetes

June 13, 1997

GLP-1 and analogues studied for diabetes

June 13, 1997

rIGF-1 + insulin improves metabolic control in IDDM patients

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...